Immutep (IMMP) Times Interest Earned (2015 - 2023)
Immutep (IMMP) posted Times Interest Earned of $0.07 for Q4 2023, up 100.05% on a QoQ basis from -$143.84 in Q2 2016.
Immutep (IMMP) Times Interest Earned (2015 - 2023) Analysis & Trends
Immutep's Times Interest Earned history runs 3 years deep, the most recent figure standing at $0.07 for Q4 2023.
- Quarterly Times Interest Earned changed N/A year-over-year to $0.07 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was $0.18 (up 67.05% YoY) and the FY2025 annual result came in at -$1655.9, down 8.81% from the prior year.
- Times Interest Earned was $0.07 for Q4 2023 at Immutep, up from -$143.84 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.07 in Q4 2023 and bottomed at $0.07 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.07 |
| Jun 30, 2016 | -143.84 |
| Jun 30, 2015 | 0.00 |